fbpx

Vaccines and “Out of the Box” Therapies for Brain Cancer

“An experimental immune-based therapy more than doubled median survival of patients diagnosed with the most aggressive malignant brain cancer Brain cancer (BC) can be difficult to treat if the patient

Continue reading

Ovarian cancer- Curcumin as Synergistic, Integrative Therapy

For ovarian cancer, treatment with curcumin alone and combined with docetaxel resulted in significant 47% and 58% reductions in tumor growth, respectively If you have been diagnosed with ovarian cancer,

Continue reading

Prostate Cancer Diagnosis- Treatment vs. Quality of Life- You Choose…

“More than 90 out of every 100 men with localised prostate cancer do not die of prostate cancer within 10yr, irrespective of whether treatment is by means of monitoring, surgery, or radiotherapy.” If

Continue reading

Multiple Myeloma Cause- HPV? Maitake, Shiitake, AHCC

Maitake, Shiitake and AHCC may all be able to kill  human papillomavirus. HPV increases the risk of myeloma. I’m taking mushrooms… Does the HPV virus cause multiple myeloma? The studies linked

Continue reading

Is Ductal Carcinoma In-Situ (DCIS) Breast Cancer or Abnormal Cells?

You have been diagnosed with Ductal Carcinoma In-Situ aka DCIS aka pre-breast cancer. Your doctor tells you… “you have noninvasive cancer”  “you have a breast lesion” “you

Continue reading

Myeloma: Preventing Myeloma-related Death

“We postulate that strategies aimed at prevention have the potential to be more effective in preventing myeloma-related death than additional pharmaceutical strategies aimed at treating advanced

Continue reading

Multiple Myeloma Survival, Dementia, Alzheimer’s- Vitamin D3 Supplementation

“Our results confirm that vitamin D deficiency is associated with a substantially increased risk of all-cause dementia and Alzheimer’s disease.” When I read the studies linked and excerpted

Continue reading

Bladder Cancer Therapy beyond Bacillus Calmette-Guérin (BCG)

The agent (CG0070) yielded an overall 12-month complete response (CR) rate of 30% in a phase 2 single-arm trial in patients with BCG-unresponsive, high-grade Ta, T1, or CIS ± Ta/T1 non-muscle-invasive

Continue reading

Myeloma – C-B-D is F.D.A. Approved AKA Mainstream?

C-B-D oil is an anti-angiogenic, multiple myeloma therapy that research has show is both cytotoxic to MM but also synergies with Velcade (bortezomib). Conventional oncology considers multiple myeloma (MM)

Continue reading

Multiple Myeloma Therapy- Thymoquinone

Our results show that Thymoquinone inhibited the proliferation of MM cells irrespective of their sensitivity to doxorubicin, melphalan or bortezomib… If you’ve been diagnosed with multiple

Continue reading

End-Stage Multiple Myeloma- Brittany Maynard was “terminal!?”

Terminal Illness is a Judgement Call. Medical Oncology’s Judgement Calls Are Wrong Too Often… I was diagnosed with multiple myeloma in early 1994. Like all newly diagnosed multiple myeloma

Continue reading

Salvage Autologous Stem Cell Transplantation

Despite advances in novel antimyeloma agents,1–4 the use of a salvage autologous stem-cell transplantation (sASCT) has continued to represent an option in well-selected patients with multiple myeloma

Continue reading